ESGMX
Price
$20.87
Change
-$0.23 (-1.09%)
Updated
Feb 21 closing price
Net Assets
954.97M
RNPHX
Price
$64.29
Change
-$0.79 (-1.21%)
Updated
Feb 21 closing price
Net Assets
147.51B
Ad is loading...

ESGMX vs RNPHX

Header iconESGMX vs RNPHX Comparison
Open Charts ESGMX vs RNPHXBanner chart's image
Mirova Global Sustainable Equity A
Price$20.87
Change-$0.23 (-1.09%)
VolumeN/A
Net Assets954.97M
American Funds New Perspective R5E
Price$64.29
Change-$0.79 (-1.21%)
VolumeN/A
Net Assets147.51B
ESGMX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ESGMX vs. RNPHX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESGMX is a Buy and RNPHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 148B vs. ESGMX (955M). RNPHX pays higher dividends than ESGMX: RNPHX (1.00) vs ESGMX (0.34). ESGMX was incepted earlier than RNPHX: ESGMX (9 years) vs RNPHX (9 years). ESGMX is a more actively managed with annual turnover of: 23.00 vs. RNPHX (17.00). RNPHX has a lower initial minimum investment than ESGMX: RNPHX (250) vs ESGMX (2500). RNPHX annual gain was more profitable for investors over the last year : 10.58 vs. ESGMX (9.20). RNPHX (34.72) and ESGMX (34.00) have equivalent 5 years return.
ESGMXRNPHXESGMX / RNPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years9 years-
Gain YTD4.9274.639106%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets955M148B1%
Annual Yield % from dividends0.341.0034%
Returns for 1 year9.2010.5887%
Returns for 3 years18.5514.84125%
Returns for 5 years34.0034.7298%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOGO7.960.08
+1.02%
Gogo
PUK17.99-0.18
-0.99%
Prudential PLC
ABTS0.41-0.01
-2.14%
Abits Group
RARE42.59-1.89
-4.25%
Ultragenyx Pharmaceutical
SMID34.74-2.37
-6.39%
Smith-Midland Corp